Insider Transactions in Q1 2023 at Outset Medical, Inc. (OM)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 20
2023
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
4,130
-3.19%
|
$82,600
$20.82 P/Share
|
Mar 20
2023
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,415
+2.11%
|
$12,735
$9.48 P/Share
|
Mar 01
2023
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
30,000
-6.78%
|
$660,000
$22.48 P/Share
|
Mar 01
2023
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+6.35%
|
$90,000
$3.88 P/Share
|
Mar 01
2023
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.62%
|
$110,000
$22.33 P/Share
|
Mar 01
2023
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.42%
|
$15,000
$3.88 P/Share
|
Feb 16
2023
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
9,984
-2.94%
|
$239,616
$24.17 P/Share
|
Feb 16
2023
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,094
+3.56%
|
$45,846
$9.48 P/Share
|
Feb 16
2023
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,559
-0.54%
|
$37,416
$24.36 P/Share
|
Feb 16
2023
|
Jean Olivier Racine Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
748
-0.47%
|
$17,952
$24.36 P/Share
|
Feb 16
2023
|
Stacey L. Porter Chief People Officer |
SELL
Open market or private sale
|
Direct |
627
-0.32%
|
$15,048
$24.36 P/Share
|
Feb 16
2023
|
Steven S. Williamson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
694
-0.55%
|
$16,656
$24.36 P/Share
|
Feb 16
2023
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,931
-0.93%
|
$46,344
$24.37 P/Share
|
Feb 16
2023
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
3,015
-0.36%
|
$72,360
$24.36 P/Share
|
Feb 02
2023
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
19,500
-5.86%
|
$585,000
$30.0 P/Share
|
Feb 02
2023
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,500
+5.54%
|
$58,500
$3.88 P/Share
|
Feb 01
2023
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.57%
|
$135,000
$27.91 P/Share
|
Feb 01
2023
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.37%
|
$15,000
$3.88 P/Share
|
Feb 01
2023
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
30,000
-6.76%
|
$840,000
$28.06 P/Share
|
Feb 01
2023
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+6.33%
|
$90,000
$3.88 P/Share
|
Jan 27
2023
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
6,281
-1.49%
|
$169,587
$27.92 P/Share
|
Jan 27
2023
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,674
-4.28%
|
$126,198
$27.92 P/Share
|
Jan 27
2023
|
Steven S. Williamson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,023
-2.32%
|
$81,621
$27.92 P/Share
|
Jan 27
2023
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,938
-4.85%
|
$133,326
$27.92 P/Share
|
Jan 27
2023
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
4,282
-5.94%
|
$115,614
$27.92 P/Share
|
Jan 27
2023
|
Stacey L. Porter Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,295
-3.43%
|
$61,965
$27.92 P/Share
|
Jan 27
2023
|
Jean Olivier Racine Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,066
-2.54%
|
$55,782
$27.92 P/Share
|
Jan 06
2023
|
Leslie Trigg Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
130,082
+13.25%
|
-
|
Jan 06
2023
|
Steven S. Williamson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
68,365
+18.28%
|
-
|
Jan 06
2023
|
Martin Vazquez Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,819
+18.84%
|
-
|
Jan 06
2023
|
Nabeel Ahmed Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,819
+19.75%
|
-
|
Jan 06
2023
|
John L. Brottem General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
41,018
+19.33%
|
-
|
Jan 06
2023
|
Jean Olivier Racine Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,018
+17.76%
|
-
|
Jan 06
2023
|
Stacey L. Porter Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,405
+18.75%
|
-
|
Jan 03
2023
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
30,000
-9.37%
|
$750,000
$25.26 P/Share
|
Jan 03
2023
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+8.57%
|
$90,000
$3.88 P/Share
|
Jan 03
2023
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-9.21%
|
$130,000
$26.14 P/Share
|
Jan 03
2023
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.43%
|
$15,000
$3.88 P/Share
|